François Ravenelle

François Ravenelle brings to Inversago a comprehensive set of skills in pharmaceutical and business development, and a proven ability to move the company’s vision forward. As CEO and Founder, François played an integral part in Inversago’s recent US$40 million raise in less than 24 months. These funds are allowing Inversago to actively pursue the development of the company’s programs, while assembling a team of senior professionals led by François to ensure a constant pace towards important clinical validations.

François’ experience spans over nearly two decades in the pharmaceutical industry, his expertise covering the entire pharmaceutical development landscape, from early-stage development programs to clinical trials, with key contribution to one approved NDA. François also participated in the successful filing and execution of clinical trials, while operating in efficient virtual pharma company environments. François Ravenelle holds a PhD in Physical Chemistry from McGill University.